These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24275009)

  • 1. Do depressed patients without activation of the hypothalamus-pituitary-adrenal (HPA) system have metabolic disturbances?
    Scharnholz B; Gilles M; Marzina A; Kommer M; Lederbogen F; Wudy SA; Hartmann MF; Westphal S; Roth HJ; Kahl KG; Meyer-Lindenberg A; Michaely HJ; Deuschle M
    Psychoneuroendocrinology; 2014 Jan; 39():104-110. PubMed ID: 24275009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-adrenal axis activity in older persons with and without a depressive disorder.
    Rhebergen D; Korten NC; Penninx BW; Stek ML; van der Mast RC; Oude Voshaar R; Comijs HC
    Psychoneuroendocrinology; 2015 Jan; 51():341-50. PubMed ID: 25462906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
    Salvat-Pujol N; Labad J; Urretavizcaya M; de Arriba-Arnau A; Segalàs C; Real E; Ferrer A; Crespo JM; Jiménez-Murcia S; Soriano-Mas C; Menchón JM; Soria V
    Psychoneuroendocrinology; 2017 Feb; 76():38-48. PubMed ID: 27883963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities.
    Licht CM; Vreeburg SA; van Reedt Dortland AK; Giltay EJ; Hoogendijk WJ; DeRijk RH; Vogelzangs N; Zitman FG; de Geus EJ; Penninx BW
    J Clin Endocrinol Metab; 2010 May; 95(5):2458-66. PubMed ID: 20237163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression.
    Ahrens T; Deuschle M; Krumm B; van der Pompe G; den Boer JA; Lederbogen F
    Psychosom Med; 2008 May; 70(4):461-7. PubMed ID: 18378864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke.
    Rosmond R; Björntorp P
    J Intern Med; 2000 Feb; 247(2):188-97. PubMed ID: 10692081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
    Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP
    J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and affective disorders in the elderly: a neuroendocrine study.
    Ferrari E; Mirani M; Barili L; Falvo F; Solerte SB; Cravello L; Pini L; Magri F
    Arch Gerontol Geriatr Suppl; 2004; (9):171-82. PubMed ID: 15207411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
    Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in major depressive disorder with or without metabolic syndrome.
    Martinac M; Babić D; Bevanda M; Vasilj I; Glibo DB; Karlović D; Jakovljević M
    Psychiatr Danub; 2017 Mar; 29(1):39-50. PubMed ID: 28291973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamus-Pituitary-Adrenal Axis, Hair Cortisol and the Metabolic Syndrome.
    Gaete HP
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S504-5. PubMed ID: 26417828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair cortisol and cortisol awakening response are associated with criteria of the metabolic syndrome in opposite directions.
    Kuehl LK; Hinkelmann K; Muhtz C; Dettenborn L; Wingenfeld K; Spitzer C; Kirschbaum C; Wiedemann K; Otte C
    Psychoneuroendocrinology; 2015 Jan; 51():365-70. PubMed ID: 25462908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not fade away: the HPA axis and depression.
    Cowen PJ
    Psychol Med; 2010 Jan; 40(1):1-4. PubMed ID: 19335939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of childhood trauma with hypothalamic-pituitary-adrenal function in borderline personality disorder and major depression.
    Carvalho Fernando S; Beblo T; Schlosser N; Terfehr K; Otte C; Löwe B; Wolf OT; Spitzer C; Driessen M; Wingenfeld K
    Psychoneuroendocrinology; 2012 Oct; 37(10):1659-68. PubMed ID: 22444624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder.
    Doolin K; Farrell C; Tozzi L; Harkin A; Frodl T; O'Keane V
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone corticotropin releasing hormone test in healthy and depressed women with and without childhood adversity.
    Spitzer C; Otte C; Kuehl LK; May A; Schultebraucks K; Hellmann-Regen J; Wingenfeld K
    Psychoneuroendocrinology; 2018 Jan; 87():147-151. PubMed ID: 29080551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
    Keller J; Gomez R; Williams G; Lembke A; Lazzeroni L; Murphy GM; Schatzberg AF
    Mol Psychiatry; 2017 Apr; 22(4):527-536. PubMed ID: 27528460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.